Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- KCISCIEScopus
- 저널 순위
- JCR Q2Scopus Q2KCI Q3
- 저널
- KOREAN JOURNAL OF INTERNAL MEDICINE39(3) · pp.501 · 2024
- 피인용
- Web of Science 5Scopus 5KCI 2
- FWCI (Scopus)
- 0.67
- JCR IF
- JCR 2023 2.2
- ISSN
- 1226-3303
저자
- Yhim, Ho-Young제1저자Jeonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Med Sch,Dept Internal Med,Jeonbuk Natl Univ Hosp, Jeonju, South Korea
- Park, YongKorea Univ, Coll Med, Anam Hosp, Dept Internal Med, Seoul, South Korea
- Kim, Jeong-ACatholic Univ Korea, St Vincent Hosp, Dept Internal Med, Suwon, Gyunggi Do, South Korea
- 신호진Pusan Natl Univ Hosp, Dept Internal Med, Pusan, South Korea
- Do, Young RokKeimyung Univ, Dongsan Med Ctr, Dept Internal Med, Daegu, South Korea
- Moon, Joon HoKyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea
- Kim, Min KyoungYeungnam Univ, Coll Med, Med Ctr, Dept Internal Med, Daegu, South Korea
- Lee, Won SikInje Univ, Busan Paik Hosp, Dept Internal Med, Pusan, South Korea
- Kim, Dae SikKorea Univ, Guro Hosp, Coll Med, Dept Internal Med, Seoul, South Korea
- Lee, Myung-WonChungnam Natl Univ, Coll Med, Dept Internal Med, Daejeon, South Korea
- Choi, Yoon SeokChungnam Natl Univ, Coll Med, Dept Internal Med, Daejeon, South Korea
- Jeong, Seong HyunAjou Univ, Sch Med, Dept Hematol Oncol, Suwon, South Korea
- Kim, Kyoung HaJeonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Med Sch,Dept Internal Med,Jeonbuk Natl Univ Hosp, Jeonju, South Korea
- Kim, JinhangCatholic Univ Korea, St Vincent Hosp, Dept Internal Med, Suwon, Gyunggi Do, South Korea
- Lee, Chang-HoonJeonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Med Sch,Dept Internal Med,Jeonbuk Natl Univ Hosp, Jeonju, South Korea
- Song, Ga-YoungChonnam Natl Univ, Hwasun Hosp, Med Sch, Dept Internal Med, Hwasun, South Korea
- Yang, Deok-Hwan교신저자Chonnam Natl Univ, Hwasun Hosp, Med Sch, Dept Internal Med, Hwasun, South Korea
- Kwak, Jae-YongJeonbuk Natl Univ, Res Inst Clin Med, Biomed Res Inst, Med Sch,Dept Internal Med,Jeonbuk Natl Univ Hosp, Jeonju, South Korea
초록
Background/Aims: Optimal risk stratification based on simplified geriatric assessment to predict treatment -related toxicity and survival needs to be clarified in older patients with diffuse large B -cell lymphoma (DLBCL). Methods: This multicenter prospective cohort study enrolled newly diagnosed patients with DLBCL (>= 65 yr) between September 2015 and April 2018. A simplified geriatric assessment was performed at baseline using Activities of Daily Living (ADL), Instrumental ADL (IADL), and Charlson's Comorbidity Index (CCI). The primary endpoint was event -free survival (EFS). Results: The study included 249 patients, the median age was 74 years (range, 65-88), and 125 (50.2%) were female. In multivariable Cox analysis, ADL, IADL, CCI, and age were independent factors for EFS; an integrated geriatric score was derived and the patients stratified into three geriatric categories: fit (n = 162, 65.1%), intermediate -fit (n = 25, 10.0%), and frail (n = 62, 24.9%). The established geriatric model was significantly associated with EFS (fit vs. intermediate -fit, HR 2.61, p < 0.001; fit vs. frail, HR 4.61, p < 0.001) and outperformed each covariate alone or in combination. In 87 intermediate -fit or frail patients, the relative doxorubicin dose intensity (RDDI) >= 62.4% was significantly associated with worse EFS (HR, 2.15, 95% CI 1.30-3.53, p = 0.002). It was related with a higher incidence of grade >= 3 symptomatic non -hematologic toxicities (63.2% vs. 27.8%, p < 0.001) and earlier treatment discontinuation (34.5% vs. 8.0%, p < 0.001) in patients with RDDI >= 62.4% than in those with RDDI < 62.4%. Conclusions: This model integrating simplified geriatric assessment can risk -stratify older patients with DLBCL and identify those who are highly vulnerable to standard dose -intensity chemoimmunotherapy.
키워드
Diffuse large B-cell lymphomaSimplified geriatric assessmentPrognosisDose intensityToxicityELDERLY-PATIENTSR-CHOPRESPONSE ASSESSMENTDOSE INTENSITYSINGLE-ARMCHEMOTHERAPYPOPULATIONSURVIVALFRAILTYTOOL
식별자
- Scopus EID
- 2-s2.0-85192680923
- WoS UID
- 001155682100001
- KCI
- ART003074207



로그인
연구물 목록으로